Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Cell Stem Cell|January 17, 2017
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseMark P Chao, Andrew J Gentles, Susmita Chatterjee, et al.Cell Reports|September 28, 2017
Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to NeuronsOrly L Wapinski, Qian Yi Lee, Albert C Chen, et al.Neuron|January 30, 2022
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibilityMandy Meijer, Eneritz Agirre, Mukund Kabbe, et al.Parkinsonism & Related Disorders|October 1, 2025
Epigenomic profile of GBA1 in Parkinson's diseaseEloise Berson, Raphael Zaghroun, Matteo Santoro, et al.Cancer Discovery|July 22, 2017
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα AgonistMichael R McKeown, M Ryan Corces, Matthew L Eaton, et al.Nature Genetics|October 27, 2020
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseasesM Ryan Corces, Anna Shcherbina, Soumya Kundu, et al.Nature Communications|August 16, 2023
Whole genome deconvolution unveils Alzheimer's resilient epigenetic signatureEloise Berson, Anjali Sreenivas, Thanaphong Phongpreecha, et al.Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
<i>APOE</i> *4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic AnalysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2026
APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.Science (New York, N.Y.)|September 13, 2021
Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injuryStephanie S Holden, Fiorella C Grandi, Oumaima Aboubakr, et al.Pageof 7